Stroke Prevention in Atrial Fibrillation and Other Major Cardiac Sources of Embolism

被引:18
|
作者
Freeman, William D. [1 ,2 ]
Aguilar, Maria I. [3 ]
机构
[1] Mayo Clin, Dept Neurol, Jacksonville, FL 32224 USA
[2] Mayo Clin, Dept Crit Care, Jacksonville, FL 32224 USA
[3] Mayo Clin, Dept Neurol, Phoenix, AZ 85054 USA
关键词
D O I
10.1016/j.ncl.2008.07.001
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
The frequency of cardioembolic stroke is expected to rise as the general population ages. Much of the increase may be attributed to atrial fibrillation, the most common cause of cardioembolic stroke and one that plays a substantial role in aging adults. Other sources of cardioembolic stroke may include ventricular thrombus from myocardial infarction, heart failure, structural heart defects such as patent foramen ovale (PFO), atrial septal aneurysm, proximal aortic atheroma, valvular heart disease, and endocarditis. Diagnostic studies, such as neuroimaging, ECG, and echocardiography, are helpful in uncovering cardioembolic sources of stroke. Medical therapy is predicated on the underlying mechanism. For example, warfarin may be indicated in certain patients who have atrial fibrillation, atrial, or ventricular thrombi, and PFO with atrial septal aneurysm and cryptogenic stroke in select young patients to prevent stroke. Newer diagnostic technologies, including multidetector CT and cardiac MRI, may be useful to diagnose cardiac causes of stroke when transesophageal echocardiography is indeterminate or cryptogenic stroke is present.
引用
收藏
页码:1129 / 1160
页数:32
相关论文
共 50 条
  • [2] Stroke severity in concomitant cardiac sources of embolism in patients with atrial fibrillation
    Kim, Young Dae
    Park, Bosuk
    Cha, Myoung Jin
    Nam, Chung Mo
    Nam, Hyo Suk
    Ha, Jong Won
    Chung, Namsik
    Heo, Ji Hoe
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2010, 298 (1-2) : 23 - 27
  • [3] APIXABAN IN THE PREVENTION OF STROKE AND SYSTEMIC EMBOLISM IN NONVALVULAR ATRIAL FIBRILLATION
    Pujadas-Mestres, L.
    Escolar, G.
    Arellano-Rodrigo, E.
    Galan, A. M.
    DRUGS OF TODAY, 2013, 49 (07) : 425 - 436
  • [4] Is left atrial appendage occlusion useful for prevention of stroke or embolism in atrial fibrillation?
    C. Stöllberger
    J. Finsterer
    G. Ernst
    B. Schneider
    Zeitschrift für Kardiologie, 2002, 91 : 376 - 379
  • [5] Is left atrial appendage occlusion useful for prevention of stroke or embolism in atrial fibrillation?
    Stöllberger, C
    Finsterer, J
    Ernst, G
    Schneider, B
    ZEITSCHRIFT FUR KARDIOLOGIE, 2002, 91 (05): : 376 - 379
  • [6] STROKE PREVENTION IN ATRIAL FIBRILLATION - A MAJOR PROBLEM IN THE REPUBLIC OF MOLDOVA
    Diaconu, N.
    Grosu, A.
    Gratii, C.
    Pavlic, G.
    EUROPEAN JOURNAL OF NEUROLOGY, 2011, 18 : 120 - 120
  • [7] Cardiac surgery interventions for stroke prevention in patients with atrial fibrillation
    Budera, Petr
    Straka, Zbynek
    COR ET VASA, 2016, 58 (02) : E242 - E249
  • [8] Therapies for the prevention of stroke and other vascular events in atrial fibrillation and atrial flutter
    Connolly, Stuart J.
    Gillis, Anne M.
    CANADIAN JOURNAL OF CARDIOLOGY, 2005, 21 : 71B - 73B
  • [9] Dabigatran etexilate for the prevention of stroke and systemic embolism in atrial fibrillation: NICE guidance
    Ahmad, Yousif
    Lip, Gregory Y. H.
    HEART, 2012, 98 (19) : 1404 - 1406
  • [10] Atrial fibrillation and stroke prevention
    Hart, RG
    NEW ENGLAND JOURNAL OF MEDICINE, 2003, 349 (11): : 1015 - 1016